Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,872 | 27,273 | 28,024 | 31,807 | 49,326 |
| Receivables | 8,471 | 4,704 | 12,120 | 6,955 | 13,130 |
| Inventories | 6,769 | 5,780 | 4,038 | 2,461 | 2,859 |
| TOTAL | $40,966 | $39,888 | $47,259 | $44,625 | $68,314 |
| Non-Current Assets | |||||
| PPE Net | 4,179 | 4,085 | 5,055 | 6,873 | 9,726 |
| Intangibles | 1,278 | 1,435 | 51 | 102 | 153 |
| Other Non-Current Assets | 10,995 | 11,662 | 9,628 | 11,284 | 286 |
| TOTAL | $16,452 | $17,182 | $14,734 | $18,259 | $10,165 |
| Total Assets | $57,418 | $57,070 | $61,993 | $62,884 | $78,479 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,926 | 9,946 | 10,339 | 9,664 | 12,274 |
| Accrued Expenses | 6,497 | 7,967 | 8,736 | 8,569 | 5,475 |
| Other current liabilities | 922 | 1,147 | 1,225 | 1,450 | N/A |
| TOTAL | $18,308 | $39,528 | $21,964 | $21,104 | $18,555 |
| Non-Current Liabilities | |||||
| Long Term Debt | 27,508 | 33,448 | 51,551 | 34,329 | 60,338 |
| Deferred Revenues | 1,551 | 1,513 | 765 | 693 | 806 |
| aiOther Non-Current Liabilities | 85,744 | 71,231 | 63,490 | 52,315 | 1,360 |
| TOTAL | $145,597 | $136,096 | $122,163 | $90,277 | $66,046 |
| Total Liabilities | $163,905 | $175,624 | $144,127 | $111,381 | $84,601 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,301 | 55,871 | 41,468 | 36,214 | 33,582 |
| Common Shares | 69 | 55 | 41 | 35 | 34 |
| Retained earnings | -319,077 | -311,207 | -256,796 | -186,257 | -130,474 |
| TOTAL | $-106,487 | $-118,554 | $-82,134 | $-48,497 | $-6,122 |
| Total Liabilities And Equity | $57,418 | $57,070 | $61,993 | $62,884 | $78,479 |